Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated:  8/23/2017
MultiCare Good Samaritan Hospital
mi
from
Puyallup, WA
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated: 8/23/2017
MultiCare Good Samaritan Hospital
mi
from
Puyallup, WA
Click here to add this to my saved trials
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated:  8/23/2017
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated: 8/23/2017
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated:  8/23/2017
Billings Clinic-Cody
mi
from
Cody, WY
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Status: Enrolling
Updated: 8/23/2017
Billings Clinic-Cody
mi
from
Cody, WY
Click here to add this to my saved trials
Preventing Health Damaging Behaviors in Male and Female Army Recruits
Preventing Health Damaging Behaviors in Male and Female Army Recruits
Status: Enrolling
Updated:  8/24/2017
Fort Jackson Advance Individual Training Units
mi
from
Columbia, SC
Preventing Health Damaging Behaviors in Male and Female Army Recruits
Preventing Health Damaging Behaviors in Male and Female Army Recruits
Status: Enrolling
Updated: 8/24/2017
Fort Jackson Advance Individual Training Units
mi
from
Columbia, SC
Click here to add this to my saved trials
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial
Status: Enrolling
Updated:  8/24/2017
New York State Psychiatric Institute
mi
from
New York, NY
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial
Status: Enrolling
Updated: 8/24/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Ending Self Stigma for PTSD
Reducing Internalized Stigma Among Veterans With PTSD: A Pilot Trial
Status: Enrolling
Updated:  8/25/2017
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Ending Self Stigma for PTSD
Reducing Internalized Stigma Among Veterans With PTSD: A Pilot Trial
Status: Enrolling
Updated: 8/25/2017
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents
Status: Enrolling
Updated:  8/28/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents
Status: Enrolling
Updated: 8/28/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression
Low Field Magnetic Stimulation in Mood Disorders: Three Daily Visits
Status: Enrolling
Updated:  8/28/2017
McLean Hospital
mi
from
Belmont, MA
Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression
Low Field Magnetic Stimulation in Mood Disorders: Three Daily Visits
Status: Enrolling
Updated: 8/28/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated:  8/28/2017
McLean Hospital
mi
from
Belmont, MA
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated: 8/28/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated:  8/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated: 8/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
Status: Enrolling
Updated:  8/28/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
Status: Enrolling
Updated: 8/28/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Women's Post Traumatic Stress Disorder (PTSD) Research Study
The Psychophysiology and Neurobiology of PTSD Across the Menstrual Cycle
Status: Enrolling
Updated:  8/29/2017
VA Boston Healthcare System
mi
from
Boston, MA
Women's Post Traumatic Stress Disorder (PTSD) Research Study
The Psychophysiology and Neurobiology of PTSD Across the Menstrual Cycle
Status: Enrolling
Updated: 8/29/2017
VA Boston Healthcare System
mi
from
Boston, MA
Click here to add this to my saved trials
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated:  8/31/2017
University of California, Los Angeles, School of Medicine
mi
from
Los Angeles, CA
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
Status: Enrolling
Updated: 8/31/2017
University of California, Los Angeles, School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
Status: Enrolling
Updated:  8/31/2017
Medical University of South Carolina, Center for Drug and Alcohol Programs
mi
from
Charleston, SC
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
Status: Enrolling
Updated: 8/31/2017
Medical University of South Carolina, Center for Drug and Alcohol Programs
mi
from
Charleston, SC
Click here to add this to my saved trials
Duration and Direct Cost of Behavioral Health Concerns in Pediatric Primary Care
Duration and Direct Cost of Behavioral Health Concerns in Pediatric Primary Care
Status: Enrolling
Updated:  8/31/2017
Munroe Meyer Institute
mi
from
Omaha, NE
Duration and Direct Cost of Behavioral Health Concerns in Pediatric Primary Care
Duration and Direct Cost of Behavioral Health Concerns in Pediatric Primary Care
Status: Enrolling
Updated: 8/31/2017
Munroe Meyer Institute
mi
from
Omaha, NE
Click here to add this to my saved trials
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data
Status: Enrolling
Updated:  8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data
Status: Enrolling
Updated: 8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Risk and Protective Factors for Rural Methamphetamine Dependence
Risk and Protective Factors for Rural Methamphetamine Dependence
Status: Enrolling
Updated:  8/31/2017
Saint Francis Medical Center Alcohol and Drug Treatment Center
mi
from
Grand Island, NE
Risk and Protective Factors for Rural Methamphetamine Dependence
Risk and Protective Factors for Rural Methamphetamine Dependence
Status: Enrolling
Updated: 8/31/2017
Saint Francis Medical Center Alcohol and Drug Treatment Center
mi
from
Grand Island, NE
Click here to add this to my saved trials
Risk and Protective Factors for Rural Methamphetamine Dependence
Risk and Protective Factors for Rural Methamphetamine Dependence
Status: Enrolling
Updated:  8/31/2017
Catholic Charities Campus for Hope
mi
from
Omaha, NE
Risk and Protective Factors for Rural Methamphetamine Dependence
Risk and Protective Factors for Rural Methamphetamine Dependence
Status: Enrolling
Updated: 8/31/2017
Catholic Charities Campus for Hope
mi
from
Omaha, NE
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Birmingham, AL
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Scottsdale, AZ
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Torrance, CA
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Orlando, FL
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Marietta, GA
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Park Ridge, IL
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Glen Burnie, MD
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Weymouth, MA
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Weymouth, MA
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Willingboro, NJ
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Willingboro, NJ
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
The Bronx, NY
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
The Bronx, NY
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Dayton, OH
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Tulsa, OK
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Charleston, SC
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Memphis, TN
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Austin, TX
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Dallas, TX
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Houston, TX
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Seattle, WA
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Brown Deer, WI
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Brown Deer, WI
Click here to add this to my saved trials
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  8/31/2017
GSK Investigational Site
mi
from
Middleton, WI
Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/31/2017
GSK Investigational Site
mi
from
Middleton, WI
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Cedars Sinai Department of Psychiatry
mi
from
Los Angeles, CA
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Cedars Sinai Department of Psychiatry
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Asher Depression Center, Northwestern University
mi
from
Chicago, IL
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Asher Depression Center, Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated:  9/7/2017
San Fernando Mental Health Center
mi
from
San Fernando, CA
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated: 9/7/2017
San Fernando Mental Health Center
mi
from
San Fernando, CA
Click here to add this to my saved trials
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated:  9/7/2017
Santa ClaritaMental Health Center
mi
from
Santa Clarita, CA
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated: 9/7/2017
Santa ClaritaMental Health Center
mi
from
Santa Clarita, CA
Click here to add this to my saved trials
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated:  9/7/2017
Mental Health Center of Denver
mi
from
Denver, CO
An Integrated Program for the Treatment of First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): RAISE Early Treatment Program
Status: Enrolling
Updated: 9/7/2017
Mental Health Center of Denver
mi
from
Denver, CO
Click here to add this to my saved trials